Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Rhea-AI Summary
Resmed (NYSE:RMD) announced that chairman and CEO Mick Farrell and CFO Aaron Bloomer will participate in the 46th Annual William Blair Growth Stock Conference in Chicago on June 2, 2026. A live, audio-only webcast starts at 4:40 p.m. CT, with a replay available for 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – RMD
In the May 20 session, RMD gained 1.00%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 19 | Sleep partnership | Positive | +1.7% | Partnership with Oura to expand sleep health education and care access. |
| Apr 30 | CFO transition | Neutral | -4.1% | Retirement of prior CFO and appointment of Aaron Bloomer as successor. |
| Apr 30 | Earnings release | Positive | -4.1% | Q3 FY2026 results with revenue growth, margin expansion, and EPS increase. |
| Apr 01 | Earnings date set | Neutral | +0.6% | Announcement of timing and access details for Q3 FY2026 earnings call. |
| Mar 03 | Sleep survey | Neutral | +0.3% | Global sleep survey results highlighting sleep as a top health priority. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows positive fundamental updates (notably strong earnings) were followed by short-term share price declines, while neutral or marketing-focused news (surveys, event announcements, partnerships) tended to coincide with modest gains or small moves.
Over the last few months, ResMed reported strong Q3 FY2026 results with higher revenue and margins and reaffirmed its fiscal 2026 outlook, yet the stock fell about 4.11% after that earnings/CFO transition day. Earlier, the company flagged its earnings date and released a global sleep survey, which saw only small price moves. A recent U.S. partnership with Oura on sleep health education coincided with a 1.69% gain. Today’s William Blair conference participation continues the pattern of investor communications and outreach rather than new financial disclosures.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 46th Annual William Blair Growth Stock Conference in Chicago, IL on Tuesday, June 2, 2026. Resmed’s webcast presentation will begin at approximately 4:40 p.m. (Central Time).
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors +1 858.221.3304 investorrelations@resmed.com | For media +1 619.510.1281 news@resmed.com |
